Shares in MaaT Pharma (Euronext: MAAT), a French microbiome company in oncology, closed 25% higher Tuesday. The company ...

Actuate Therapeutics (ACTU) announced key takeaways from its Key Opinion Leader event held on May 31, 2025 discussing the topline results from the Phase 2 trial of elraglusib in combination with ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced that the European ...

Bangalore-based Biocon has secured approval from the Central Drugs Standard Control Organisation (CDSCO) for Liraglutide, a ...

While the government is striving hard to boost exports to achieve sustainable economic growth, the pharmaceutical ...